JNK inhibition alleviates delayed neurocognitive recovery after surgery by limiting microglia pyroptosis

•Delayed neurocognitive recovery is a prevalent cognitive disorder following surgery.•Neuroinflammation plays a key role in the etiology of delayed neurocognitive recovery.•Microglia are vital mediators in the initiation and progression of neuroinflammation.•Pyroptosis is a type of inflammatory cell...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International immunopharmacology 2021-10, Vol.99, p.107962-107962, Article 107962
Hauptverfasser: He, Jindan, Liu, Taotao, Li, Yue, Mi, Xinning, Han, Dengyang, Yang, Ning, Chen, Lei, Li, Yitong, Hong, Jingshu, Kuang, Chongshen, Yuan, Yi, Cao, Yiyun, Han, Yongzheng, Shi, Chengmei, Li, Zhengqian, Guo, Xiangyang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Delayed neurocognitive recovery is a prevalent cognitive disorder following surgery.•Neuroinflammation plays a key role in the etiology of delayed neurocognitive recovery.•Microglia are vital mediators in the initiation and progression of neuroinflammation.•Pyroptosis is a type of inflammatory cell death that contributes to neuroinflammation.•The JNK pathway is crucial for pyroptosis-mediated inflammatory responses. Delayed neurocognitive recovery (dNCR) is a prevalent complication after surgery in older adults. Neuroinflammation plays a pivotal role in the pathogenesis of dNCR. Recently,compelling evidence suggests that theinvolvement of microglia pyroptosis in the regulation of neuroinflammation in neurologicaldiseases. Nevertheless, the exact role of microglia pyroptosis in dNCR remains elusive. In the study, in vitro and in vivo models of dNCR were used to examine the potential effects of the mitogen‑activated protein kinase signaling pathway on Nod-like receptor protein 3 (NLRP3) inflammasome-mediated microglia pyroptosis and cognitive deficits following surgery. In vivo, we observed surgery-induced upregulation of phosphorylated (p)-c-Jun N-terminal kinases (JNK) in microglia and subsequently NLRP3 inflammasome activation, pyroptosis, and inflammatory cytokines release in mice hippocampus. Interestingly, JNK inhibitor SP600125 significantly attenuated surgery-induced cognitive impairments through inhibiting pyroptosis, inflammatory responses, and reducing immunoreactivity of NLRP3 and gasdermin D N terminus (GSDMD-N) in hippocampal microglia. In vitro, NLRP3 inflammasome- and pyroptosis-associated proteins and immunoreactivity of NLRP3, GSDMD-N, and interleukin-1β were activated in BV2 microglial cells following lipopolysaccharide (LPS) stimulation. These effects were significantly suppressed in BV2 cells by SP600125 treatment. Furthermore, treatment with NLRP3 specific inhibitor, MCC950, attenuated microglia pyroptosis induced by LPS, but did not rescue LPS-induced increased expression of p-JNK. These results indicate that the JNK pathway is largely upstream of the NLRP3 inflammasome, which exerts a crucial regulatory impact on microglia pyroptosis and inflammatory responses, thus providing a promising avenue to prevent dNCR.
ISSN:1567-5769
1878-1705
DOI:10.1016/j.intimp.2021.107962